Get started
Author

S. S. Safronova

Observed names: E. A. Ljaljukova, I. V. Druk, S.S. Safronova, S.S. Safronova Safronova, Safronova S.S. Safronova, С.С. Сафронова, Сафронова С.С., Сафронова Светлана Сергеевна
ORCID: 0000-0001-5852-2782
Observed ORCID: 0000-0001-5852-2782
OpenAlex ID: A5003887529
Obesity: current state of the problem, multidisciplinary approach. (based on the consensus of the World Gastroenterological Organization “Obesity 2023” and the European guideline on obesity care in patients with gastrointestinal and liver diseases, 2022)
2024 · M. A. Livzan, E. A. Lyalyukova, et al. · Экспериментальная и клиническая гастроэнтерология · 4
PDF
Biomarkers of heart failure in patients with type 2 diabetes mellitus: clinical comparisons and impact of hypoglycemic therapy
2025 · I. V. Druk, S. S. Safronova, et al. · Zabajkalʹskij medicinskij vestnik · 1
PDF
Gastroesophageal reflux disease, obesity, bronchial asthma: simple combination or complex interaction
2024 · I. V. Druk, E. V. Usacheva, et al. · Экспериментальная и клиническая гастроэнтерология · 1
PDF
Empathy spectrum in clinical residents: the role of age, year of study, and specialty
2026 · I. V. Druk, E. V. Usacheva, et al. · CARDIOVASCULAR THERAPY AND PREVENTION
PDF
Hepatitis with a high degree of activity and multiple organ lesions on the background of Cytomegalovirus infection
2026 · I. V. Druk, E. A. Ljaljukova, et al. · Экспериментальная и клиническая гастроэнтерология
PDF
Факторы, Ассоциированные С Гипертрофией Левого Желудочка У Пациентов С Сахарным Диабетом 2 Типа И Гипертонической Болезнью
2026 · И.В. Друк, С.С. Сафронова, et al. · Современные проблемы науки и образования
PDF
Results of an open, prospective, comparative study of the efficacy of ipragliflozin in a group of patients with type 2 diabetes mellitus, hypertension, and left ventricular diastolic dysfunction
2026 · S.S. Safronova, I.V. Druk, et al. · Русский медицинский журнал
Predictive risk factors for left ventricular diastolic dysfunction in comorbid patients with type 2 diabetes mellitus and hypertension
2026 · S.S. Safronova, I.V. Druk, et al. · Русский медицинский журнал
Influence of ipragliflosin on cardiac electrical activity in patients with type 2 diabetes mellitus and arterial hypertension
2025 · Druk I.V. Druk, Safronova S.S. Safronova, et al. · Therapy
Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study
2025 · S.S. Safronova Safronova, I.V. Druk Druk, et al. · Фарматека
Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy
2025 · I.V. Druk Druk, S.S. Safronova Safronova, et al. · Фарматека
Metabolic and cardioprotective effects of ipragliflozin in patients with type 2 diabetes mellitus and arterial hypertension
2025 · I.V. Druk, S.S. Safronova, et al. · Russian Medical Inquiry
Glycemic control and cardiovascular complications of type 2 diabetes mellitus
2023 · I. V. Druk, S. S. Safronova · Meditsinskiy sovet = Medical Council
Гликемический контроль и сердечно-сосудистые осложнения сахарного диабета
2023 · Друк Инна Викторовна, Сафронова Светлана Сергеевна · Медицинский Совет
Works count: 15
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type